References
- Vainas G, Pasaitou V, Galaktidou G, Maris K, Christodoulou K, Constantinidis C, et al. The role of somatostatin analogues in complete antiandrogen treatment in patients with prostatic carcinoma. J Exp Clin Cancer Res 1997; 16: 119–26
- Koutsilieris M, Mitsiades C, Dimopoulos T, Ioannidis A, Ntounis A, Lambou T. A combination therapy of dexamethasone and somatostatin analog reintroduces objective clinical responses to LHRH analog in androgen ablation-refractory prostate cancer patients. J Clin Endocrinol Metab 2001; 86: 5729–36
- Logothetis CJ, Hossan EA, Smith TL. SMS 201-995 in the treatment of refractory prostatic cancer. Anticancer Res 1994; 14: 2731–4
- Gradon JD, Schulman RH, Chapnick EK, Sepkowitz DV. Octreotide induced acute pancreatitis in a patient with acquired immunodeficiency syndrome. South Med J 1991; 84: 1410–1
- Velosy B, Madacsy L, Szepes A, Pavics L, Csernay L, Lonovics J. The effects of somatostatin and octreotide on the human sphincter of Oddi. Eur J Gastroenterol Hepatol 1999; 11: 897–901